The HTLV-1 neurological complex (Q36655609)

15 August 2017

1 reference

title

The HTLV-1 neurological complex (English)

1 reference

Human T-lymphotropic virus 1

15 August 2017

0 references

author name string

Abelardo Q C Araujo

series ordinal

1

1 reference

PubMed ID

17110288

15 August 2017

Marcus Tulius T Silva

series ordinal

2

1 reference

15 August 2017

1 December 2006

1 reference

15 August 2017

1 reference

15 August 2017

5

1 reference

15 August 2017

12

1 reference

15 August 2017

1068-1076

1 reference

Human T-lymphotropic virus type II and neurological disease.

15 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

HTLV-1-associated diseases

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Immunopathogensis of HTLV-I associated neurologic disease: molecular, histopathologic, and immunologic approaches

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

A spastic paraplegic syndrome in South India.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

The history of discovery and clinico-epidemiology of HTLV-I-associated myelopathy(HAM).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Proposal for diagnostic criteria of tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Progression of neurological disability in HTLV-I-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Gender influence on the progression of HTLV-I associated myelopathy/tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Usefulness of proviral load measurement for monitoring of disease activity in individual patients with human T-lymphotropic virus type I-associated myelopathy/tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Post-transplantation HTLV-1 myelopathy in three recipients from a single donor

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Risk factors and cofactors for human T-cell lymphotropic virus type I (HTLV-I)-associated myelopathy/tropical spastic paraparesis (HAM/TSP) in Jamaica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

HTLV-I-associated myelopathy/tropical spastic paraparesis in Brazil: a nationwide survey. HAM/TSP Brazilian Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

HTLV-I negative tropical spastic paraparesis: a scientific challenge

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Defective human T-cell lymphotropic virus type I (HTLV-I) provirus in seronegative tropical spastic paraparesis/HTLV-I-associated myelopathy (TSP/HAM) patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

HTLV-I associated tropical spastic paraparesis. Cerebral spinal fluid evolutive aspects in 128 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Intrathecal humoral immune response in HAM/TSP in relation to HLA haplotype analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Human T lymphotropic virus type I (HTLV-I) proviral load in cerebrospinal fluid: a new criterion for the diagnosis of HTLV-I-associated myelopathy/tropical spastic paraparesis?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Spinal cord swelling in human T-lymphotropic virus 1-associated myelopathy/tropical spastic paraparesis: magnetic resonance indication for early anti-inflammatory treatment?

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

An autoaggressive process against bystander tissues in HTLV-I-infected individuals: a possible pathomechanism of HAM/TSP.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Cellular immune response to HTLV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

The immune response to HTLV-I.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Immunological studies in tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

HTLV-I associated myelopathy/tropical spastic paraparesis (HAM/TSP): a chronic progressive neurologic disease associated with immunologically mediated damage to the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Immunocytochemical analysis of the cellular infiltrate in the spinal cord lesions in HTLV-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

HLA alleles determine human T-lymphotropic virus-I (HTLV-I) proviral load and the risk of HTLV-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Differences in viral and host genetic risk factors for development of human T-cell lymphotropic virus type 1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis between Iranian and Japanese HTLV-1-infected individuals

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Polygenic control of human T lymphotropic virus type I (HTLV-I) provirus load and the risk of HTLV-I-associated myelopathy/tropical spastic paraparesis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Interferon-alpha is effective in HTLV-I-associated myelopathy: a multicenter, randomized, double-blind, controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

A prospective uncontrolled trial of fermented milk drink containing viable Lactobacillus casei strain Shirota in the treatment of HTLV-1 associated myelopathy/tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Susceptibility of human T cell leukemia virus type I to nucleoside reverse transcriptase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

High-dose zidovudine induction in HTLV-I-associated myelopathy: safety and possible efficacy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Effect of lamivudine on human T-cell leukemia virus type 1 (HTLV-1) DNA copy number, T-cell phenotype, and anti-tax cytotoxic T-cell frequency in patients with HTLV-1-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

The effect of antiretroviral therapy on HTLV infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Quantification of the virus-host interaction in human T lymphotropic virus I infection.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

HIV type 1 protease inhibitors fail to inhibit HTLV-I Gag processing in infected cells.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Strongyloides stercoralis hyperinfection in a carrier of HTLV-I virus with evidence of selective immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Tropical spastic paraparesis/human T leukemia virus type 1-associated myelopathy in HIV type 1-coinfected patients

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Skeletal muscle involvement in tropical spastic paraparesis/HTLV-1-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Inflammatory, immune, and viral aspects of inclusion-body myositis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

HTLV-1 and polymyositis in Jamaica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Clinical characteristics of HTLV-1 associated dermato-polymyositis. Seven cases from Martinique.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Detection of HTLV-I provirus by in situ polymerase chain reaction in mononuclear inflammatory cells in skeletal muscle of viral carriers with polymyositis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Muscle wasting induced by HTLV-1 tax-1 protein: an in vitro and in vivo study

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

HTLV-1 associated polymyositis in Jamaica

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

The clinical and pathological features of peripheral neuropathy accompanied with HTLV-I associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Neurological manifestations in HTLV-I-infected blood donors

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Peripheral neuropathy in HTLV-I infected individuals without tropical spastic paraparesis/HTLV-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Autopsy report of HTLV-I-associated myelopathy presenting with ALS-like manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

ALS syndrome in HTLV-I infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Response to corticosteroid therapy in a patient with HTLV-I-associated motor neuron disease.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Neuropsychological assessment in HTLV-1 infection: a comparative study among TSP/HAM, asymptomatic carriers, and healthy controls

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Dysautonomia in human T-cell lymphotrophic virus type I-associated myelopathy/tropical spastic paraparesis

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Circadian rhythms of blood pressure and heart rate in patients with human T-lymphotropic virus type-I-associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Nocturnal hypertension and autonomic dysfunction due to human T-lymphotropic virus type-1 (HTLV-1)-associated myelopathy/tropical spastic paraparesis (HAM/TSP).

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

The seroprevalence of HTLV-I in patients with ocular diseases, pregnant women and healthy volunteers in the Kanto district, central Japan.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Leukoencephalopathy in HTLV-I-associated myelopathy/tropical spastic paraparesis: MRI analysis and a two year follow-up study after corticosteroid therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Acute disseminated encephalomyelitis following HTLV-I associated myelopathy

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Spinocerebellar syndrome in patients infected with human T-lymphotropic virus types I and II (HTLV-I/HTLV-II): report of 3 cases from Panama

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Acute myelopathy and cerebellar signs associated with uveitis with positive serum and cerebrospinal fluid antibodies to HTLV-I.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Chronic progressive spinocerebellar syndrome associated with antibodies to human T-lymphotropic virus type I: clinico-virological and magnetic resonance imaging studies

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Central nervous system lesions in adult T-cell leukaemia: MRI and pathology

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

HTLV-I-associated meningitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Severe strongyloidiasis complicated by meningitis and hydrocephalus in an HTLV-1 carrier with increased proviral load.

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Cryptococcal meningitis in a patient with chronic adult T-cell leukemia in complete remission

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

Chronic hypertrophic cranial pachymeningitis associated with HTLV-I infection

1 reference

https://api.crossref.org/works/10.1016%2FS1474-4422%2806%2970628-7

7 January 2021

10.1016/S1474-4422(06)70628-7

Identifiers

DOI

1 reference

15 August 2017

1 reference

PubMed ID

17110288